Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II Study.
Ann Surg
; 278(3): e511-e518, 2023 09 01.
Article
in En
| MEDLINE
| ID: mdl-36762546
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Esophageal Neoplasms
/
Adenocarcinoma
Limits:
Humans
Language:
En
Journal:
Ann Surg
Year:
2023
Document type:
Article